BOSTON (MarketWatch) -- Eli Lilly & Co. reported dramatically higher second-quarter earnings early Thursday, due largely to hefty acquisition charges taken during last year's quarter. For the quarter ended June 30, Lilly (LLY:LLYNews, chart, profile, ...
[1 hour ago - MarketWatch]